Skip to main content

and
  1. Article

    Open Access

    Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma

    Mantle cell lymphoma (MCL) is a lethal hematological malignancy with a median survival of 4 years. Its lethality is mainly attributed to a limited understanding of clinical tumor progression and resistance to ...

    Anuvrat Sircar, Satishkumar Singh, Zijun Y. Xu-Monette, Krysta Mila Coyle in Leukemia (2023)

  2. Article

    Open Access

    Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents

    Mantle cell lymphoma is a B cell non-Hodgkin lymphoma (NHL), representing 2–6% of all NHLs and characterized by overexpression of cyclin D1. The last decade has seen the development of many novel treatment app...

    Neeraj Jain, Mukesh Mamgain, Sayan Mullick Chowdhury in Journal of Hematology & Oncology (2023)

  3. Article

    Open Access

    A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells

    Mantle cell lymphoma (MCL) is a rare, highly heterogeneous type of B-cell non-Hodgkin’s lymphoma. The sumoylation pathway is known to be upregulated in many cancers including lymphoid malignancies. However, li...

    Walter Hanel, Pushpa Lata, Youssef Youssef, Ha Tran in Experimental Hematology & Oncology (2022)

  4. No Access

    Article

    Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer

    Bladder cancer (BLCA) is the most common malignant tumor of the urinary system and is characterized by high metastatic rates and poor prognosis. The expression of tight junction protein 1 (TJP1) is associated ...

    Xue-Qi Liu, **n-Rong Shao, Ye Liu, Zhao-**a Dong, Sze-Hoi Chan, Yuan-Yuan Shi in Oncogene (2022)

  5. Article

    Open Access

    Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia

    Carolina Vicente-Dueñas, Inés González-Herrero, Lalit Sehgal in Leukemia (2019)

  6. Article

    Open Access

    Targeting Wnt pathway in mantle cell lymphoma-initiating cells

    Mantle cell lymphoma (MCL) is an aggressive and incurable form of non-Hodgkin’s lymphoma. Despite initial intense chemotherapy, up to 50 % of cases of MCL relapse often in a chemoresistant form. We hypothesize...

    Rohit Mathur, Lalit Sehgal, Frank K. Braun in Journal of Hematology & Oncology (2015)

  7. Article

    Open Access

    CD74 interferes with the expression of fas receptor on the surface of lymphoma cells

    Resistance to Fas-mediated apoptosis limits the efficacy of currently available chemotherapy regimens. We identified CD74, which is known to be overexpressed in hematological malignancies, as one of the factor...

    Zuzana Berkova, Shu Wang, Xue Ao in Journal of Experimental & Clinical Cancer … (2014)

  8. Article

    Open Access

    Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma

    Fascin is a globular actin cross-linking protein, which plays a major role in forming parallel actin bundles in cell protrusions and is found to be associated with tumor cell invasion and metastasis in various...

    Hunain Alam, Amruta V Bhate, Prakash Gangadaran, Sharda S Sawant in BMC Cancer (2012)